Macaulay Capital PLC - Extension of warrant exercise date & Director loan
Announcement provided by
Macaulay Capital PLC · MCAP26/07/2024 07:00
26 July 2024
Macaulay Capital PLC
("Macaulay Capital" or the "Company")
Extension of warrant exercise date and Director loan
Macaulay Capital PLC (AQSE:MCAP), which was formed to originate and manage corporate transactions, raise funds from third parties, invest its own funds alongside those of external investors and to manage its investment portfolio with the aim of maximising its value, announces the extension of the exercise date for certain warrants and also a loan to be made to the Company by its Managing Director, David Horner.
As set out in the Company's AQSE admission document dated 25 July 2022, Harry and Tom Horner (the adult sons of David Horner) each hold 3,000,000 warrants ("Unconditional Founder Warrants") that were required to be exercised at a subscription price of
In addition, David Horner has agreed to lend the Company
As David Horner is a director of the Company and Harry and Tom Horner are both substantial shareholders, the Warrant Extension and the Loan are deemed to be related party transactions under the AQSE Rules. The Company's other directors, Lindsay Mair and Richard Bucknell, having exercised reasonable care, skill and diligence, believe that the Warrant Extension and the Loan are fair and reasonable as far as the shareholders of the Company are concerned.
This announcement contains inside information for the purposes of the
ENDS
Enquiries:
Macaulay Capital PLC |
|
Clive Milner |
+44 (0)20 3946 5980 |
|
|
Cairn Financial Advisers LLP (AQSE Corporate Adviser) |
|
Louise O'Driscoll
|
+44 (0)20 7213 0880 |
Oberon Capital (Broker) |
|
Chris Crawford |
+44 (0)20 3179 5304 |
For more information please visit: www.macaulaycapital.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.